New Directory: Top 60 Biopharmaceutical Manufacturers in INDIABioPlan Associates, Inc.May 1, 2008 310 Pages - SKU: DFAQ1742277 |
| Countries covered: China, India The first edition of the BioPlan India Biopharmaceutical Index includes the Top 60 Biopharmaceutical Companies in India, with detailed profiles of their business focus, products, revenues, R&D and business strategies, international objectives, partnering strategies, and marketing activities. In addition, subscribers will receive on-going updates to activities and trends in India as the country’s biopharmaceutical industry expands. Our India Biopharmaceutical Index and our Top 60 Directory provide you information on trending of activities and changes occurring in the region. Be sure to keep up-to-date on Who’s Who in India. This report will help ensure you’re current, and have a solid understanding of this dynamic, rapidly changing market. Our ranking of the Top 60 organizations is done using our proprietary profile analysis and assessment process. Over 300 pages profiling: Company Overview and History Senior Managers' Overview Ownership and Subsidiaries Detailed Financial Data Employee Data Partnering Opportunities Product Information Manufacturing Information International GMP Certifications Corporate Agreements Technological and Regulatory Aspects International Partnering Objectives R&D activities Challenges Future Plans More... Unique and hard-to-find primary information profiles business focus, and partnering strategies. Stay current on trends, changes, and "Who's Who" in India biopharma. Ensure you've got a solid understanding of this dynamic, rapidly changing market. |
More India Biopharmaceuticals Reports
Strategic Analysis of Indian Biosimilar Market by
Frost & Sullivan
This research deliverable provides deep insights into the Biosimilar market in India. It also includes an overview of the Indian regulatory and R&D process briefing ...
Bringing Biologics to Market in the BRIC Countries by
Decision Resources
Pharmaceutical companies are realizing the lucrative opportunities for growth offered by biologics because these high-priced drugs can target growing niche markets, compensate for dwindling pipelines, ...
The 2009-2014 Outlook for Biologics in India by
Icon Group International, Inc.
This econometric study covers the latent demand outlook for biologics across the states, union territories and cities of India. Latent demand (in millions of U.S. ...
Directory of Top 60 Biopharmaceutical Manufacturers in INDIA by
BioPlan Associates, Inc.
A comprehensive industry review: profiles of the established, and rapidly growing, organizations involved in ...
Indian Biopharmaceuticals by
Cygnus Business Consulting and Research
India is counted among the top 12 global biotech hotspots and is the 3rd largest in Asia Pacific (in terms of number of biotech companies). ...
See all reports like this >>
More India Reports
D&B Country RiskLine Report: India by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: India by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report India January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
India: Country Profile by
MarketLine
INTRODUCTION This report provides a detailed analysis on India, providing an overview of its political, economic and business environment, represented both textually and in graph and ...
2007 India Industry & Market Outlook report by
Barnes Reports
The 2007 India Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in India and 500+ minor industries ...
See all reports like this >>
Related Markets
- Biotechnology
- Research & Development
- Pharmaceuticals
- Manufacturing, Packaging & Detailing
- Biopharmaceuticals
Biopharmaceuticals Reports
- Research Report on Chinese Bio-pharmaceutical Industry, 2012
- Regulatory Intelligence on Biologics Recalls – Immunoglobulins and Vaccines are Involved in More Recalls than Other Drug Classes
- Biologics Market in Brazil
- Global Biosimilars Market Forecast to 2015
- Biosimilars: Current Situation & Future Prospects, Worldwide
